Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (TNFALPHA) monoclonal antibody for Crohn's disease

被引：14
|
作者：
Bank, L
Hunt, B
机构：
[1] Univ Med Associates, Binghamton, NY USA
[2] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2002年 / 97卷 / 09期
关键词：
D O I：
10.1016/S0002-9270(02)05276-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
793
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [1] Dramatic Response to Ustekinumab Treatment in a Patient with Ankylosing Spondylitis and Crohn's Disease and Anti-tumor Necrosis Factor-alpha Drug Induced Psoriasis
    Kilic, Sevilay
    Resorlu, Hatice
    Ekinci, Alper
    Keskin, Ayse Selcen Bulut
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2020, 26 (03): : 197 - 200
  • [2] Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor α monoclonal antibody
    Tan, MH
    Gordon, M
    Lebwohl, O
    George, J
    Lebwohl, MG
    ARCHIVES OF DERMATOLOGY, 2001, 137 (07) : 930 - 933
  • [3] Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
    Oh, CJ
    Das, KM
    Gottlieb, AB
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (05) : 829 - 830
  • [4] Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease
    Esters, N
    Vermeire, S
    Joossens, S
    Noman, M
    Louis, E
    Belaiche, J
    De Vos, M
    Van Gossum, A
    Pescatore, P
    Fiasse, R
    Pelckmans, P
    Reynaert, H
    Poulain, D
    Bossuyt, X
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06): : 1458 - 1462
  • [5] Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
    Uri Netz
    Jane Victoria Carter
    Maurice Robert Eichenberger
    Gerald Wayne Dryden
    Jianmin Pan
    Shesh Nath Rai
    Susan Galandiuk
    World Journal of Gastroenterology, 2017, 23 (27) : 4958 - 4967
  • [6] Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
    Netz, Uri
    Carter, Jane Victoria
    Eichenberger, Maurice Robert
    Dryden, Gerald Wayne
    Pan, Jianmin
    Rai, Shesh Nath
    Galandiuk, Susan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (27) : 4958 - 4967
  • [7] Treatment of pediatric Crohn's disease (CD) with anti-tumor necrosis factor α chimeric monoclonal antibody (infliximab)
    Kugathansan, S
    Rivera, MT
    Martinez, A
    Binion, DG
    Werlin, SL
    GASTROENTEROLOGY, 1999, 116 (04) : A755 - A755
  • [8] Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor α antibody (infliximab) in Crohn's disease
    Detková, Z
    Kupcova, V
    Príkazská, M
    Turecky, L
    Weissová, S
    Jahnová, E
    PHYSIOLOGICAL RESEARCH, 2003, 52 (01) : 95 - 100
  • [9] Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease
    Zaccagna, A
    Bertone, A
    Puiatti, P
    Picciotto, F
    Sprujevnik, T
    Santucci, R
    Rossini, FP
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (03) : 258 - 260
  • [10] Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
    Gottlieb, AB
    Masud, S
    Ramamurthi, R
    Abdulghani, A
    Romano, P
    Chaudhari, U
    Dooley, LT
    Fasanmade, AA
    Wagner, CL
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (01) : 68 - 75
12345